The involvement of uric acid in the pathogenesis of preeclampsia

Current Hypertension Reviews

Volumn 11, Issue 2, 2015, Pages 110-115

  Masoura, Sophia ^a   Makedou, Kali ^a   Theodoridis, Theodoros ^a   Kourtis, Anargyros ^a   Zepiridis, Leonidas ^a   Athanasiadis, Apostolos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antioxidant; Biomarker; Oxidant; Pathogenesis; Preeclampsia; Uric acid

Indexed keywords

BIOLOGICAL MARKER; CRYOPYRIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; REACTIVE OXYGEN METABOLITE; URIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERURICEMIA; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DYSFUNCTION; MATERNAL MORBIDITY; NEWBORN MORTALITY; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PURINE METABOLISM; BLOOD; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME;

FEMALE; HUMANS; HYPERURICEMIA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; URIC ACID;

EID: 84939779984     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111666150529130703     Document Type: Article

References (36)

1. [1] Villar J, Say L, Shennan A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004; 85: S28-41.
2. [2] Merviel P, Carbillon L, Challier JC, Rabreau M, Beaufils M, Uzan S. Pathophysiology of preeclampsia: Links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 2004; 115: 134-47.
3. [3] Kam EP, Loke YW, King A. The role of trophoblast in the physiological change in decidual spiral arteries. Human Reprod 1999; 14: 2131-38.
4. [4] Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human. Placenta 2009; 30(6): 473-82.
5. [5] Raijamkers MT, Dechend R, Poston L. Oxidative stress and Preeclampsia: Rationale for antioxidant clinical trials. Hypertension 2004; 44: 374-80.
6. [6] Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med 2008; 59: 61-78.
7. [7] Maynard S, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol 2011; 31: 33-46.
8. [8] Slemons JM, Bogert LJ. The uric acid content of maternal and fetal blood. J Bioch 1917; 32: 63-9.
9. [9] Lam C, Kimk H, Kang DH, Karumanchi SA. Uric acid and Preeclampsia. Semin Nephrol 2005; 25: 56-60.
10. [10] Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008; 29: S67-72.
11. [11] Powers RW, Bodnar LM, Ness RB, et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006; 194: 160.
12. [12] Soltani Z, Rasheed K, Kapusta DR, Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 2013; 15(3): 175-81.
13. [13] Ames BN, Cathcart R, Scwiers E, Hochstein P. Uric acid provides an antioxidant defence in humans against oxidant- and radicalcaused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-62.
14. [14] Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748-52.
15. [15] Schulz E, Gori T, Münzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 2011; 34: 665-73.
16. [16] Hayden MR, Tyagi SC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab 2004; 19: 1-10.
17. [17] Glantzoulis GK, Tsimoyannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharmac 2005; 11: 415-51.
18. [18] Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, et al (2005) Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005; 46: 1263-69.
19. [19] Suzuki S, Yoneyama Y, Sawa R, Otsubo Y, Takeuchi T, Araki T. Relation between serum uric acid and plasma adenosine in women with preeclampsia. Gynecol Obstet Invest 2001; 51: 169-72.
20. [20] Many A, Hubel CA, Fisher SJ, Roberts JM. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000; 156: 321-31.
21. [21] Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid induced Creactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-62.
22. [22] Bainbridge SA, Roberts JM, Hoynck FV, Koch J, Edmunds L, Cubel CA. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol 2009; 297: c440-50.
23. [23] Rubartelli A, Lotze MT. Inside, outside, upside down: damageassociated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2007; 28: 429-36.
24. [24] Mulla MJ, Myrtolli K, Potter J, et al. Uric acid induces Trophoblast IL-1β production via the inflammasome: implication in the pathogenesis of preeclampsia. Am J Reprod Immunol 2011; 65: 542-48.
25. [25] Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation and vascular disease. Semin Nephrol 2005; 25: 39-42.
26. [26] Khosia UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-42.
27. [27] Kang DH, Finch JL, Nakagawa T, et al. Uric acid, endothelial dysfunction and preeclampsia. J Hypertens 2004; 22: 229-35.
28. [28] Dopp JM, Philippi NR, Marcus NJ, et al. Xanthine Oxidase Inhibition Attenuates Endothelial Dysfunction Caused by Chronic Intermittent Hypoxia in Rats. Respiration 2011; 82: 458-67.
29. [29] Yinon Y, Kingdom JC, Odutayi A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction; insights to future vascular risk. Circulation 2010; 122: 1846-53.
30. [30] De Oliveira LG, Karumanchi A, Saa N. Preeclampsia: oxidative stress, inflammation and endothelial dysfunction. Rev Bras Gynecol Obstet 2010; 32: 609-16.
31. [31] Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993; 169: 1112-18.
32. [32] Masoura S, Kalogiannidis I, Margioula-Siarkou Ch, et al. Neonatal outcome of late preterm deliveries with preeclampsia. Minerva Gynecol 2012; 64: 109-15.
33. [33] Salam RA, Das JK, Bhutta ZA. Impact of intrauterine growth restriction on long-term health. Curr Opin Clin Nutr Metab Care 2014; 17(3): 249-54.
34. [34] Bainbridge SA. Uric acid inhibits placental System A amino acid uptake. Placenta 2009; 30: 195-200.
35. [35] Mahendran D, Donnai P, Glazier JD, D’Souza SW, Boyd RD, Sibley CP. Amino acid (system A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res 1993; 34: 661-65.
36. [36] Vitoratos N, Hassiakos D, Lavazzo C. Molecular mechanisms of preeclampsia. J Pregnancy 2012; 2012: 298343.